Catalog No.
YVV31801
Expression system
E. coli
Species
Zika virus (ZIKV)
Protein length
Ser130-Arg215
Predicted molecular weight
37.91 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q32ZE1
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein, Capsid protein C, Capsid protein, Core protein, Protein prM, Precursor membrane protein, Peptide pr, Peptide precursor, Small envelope protein M, Matrix protein, Envelope protein E, Non-structural protein 1, NS1, Non-structural protein 2A, NS2A, Serine protease subunit NS2B, Flavivirin protease NS2B regulatory subunit, Non-structural protein 2B, Serine protease NS3, 3.4.21.91, 3.6.1.15, 3.6.4.13, Flavivirin protease NS3 catalytic subunit, Non-structural protein 3, Non-structural protein 4A, NS4A, Peptide 2k, Non-structural protein 4B, NS4B, RNA-directed RNA polymerase NS5, 2.1.1.56, 2.1.1.57, 2.7.7.48, NS5
The Entry of Zika Virus into the Cells and Its Implication for Antiviral Therapy., PMID:40512550
Structural basis for antibody cross-neutralization of dengue and Zika viruses., PMID:40502094
Diagnostic Techniques for Dengue Virus., PMID:40495084
Neurovirulence of Zika virus-encoded proteins., PMID:40483309
Purification, refolding, and pH-dependent stability evaluation of Zika virus EDIII protein., PMID:40478414
Zika virus infection in a non-neural cell host promotes differential expression of proteins associated with neurological conditions., PMID:40465939
The role of iron in normal and impaired testicular function., PMID:40464377
UFMylation promotes orthoflavivirus infectious particle production., PMID:40459261
Antiviral in vitro activity of a novel dichlorinated tyrosine methyl ester derivative against the infection of two flaviviruses of public health concern, dengue and zika virus., PMID:40450991
Defining neuronal responses to the neurotropic parasite Toxoplasma gondii., PMID:40444956
From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity., PMID:40432061
The Emerging Role of Circulating T Follicular Helper Cells in Dengue Virus Immunity: Balancing Protection and Pathogenesis., PMID:40431664
Identification of TRIM21 and TRIM14 as Antiviral Factors Against Langat and Zika Viruses., PMID:40431659
Serologic Surveillance for Orthoflaviviruses and Chikungunya Virus in Bats and Opossums in Chiapas, Mexico., PMID:40431603
A VLPs based vaccine protects against Zika virus infection and prevents cerebral and testicular damage., PMID:40425591
Estimating ZIKV seroprevalence in a DENV endemic population: the use of blood donors and multiplex serology to monitor arbovirus outbreaks in the Dutch Caribbean., PMID:40420834
Autophagy-mediated downregulation of AXL and TIM-1 promotes sustained Zika virus infection., PMID:40408405
Seroprevalence and Placental Transfer of Zika and Dengue Virus Antibodies in Postpartum Women in Southeast Brazil., PMID:40400258
A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses., PMID:40364846
Extracellular nucleotides mediate viral central nervous system infections: key alarmins of neuroinflammation and neurodegeneration., PMID:40364625
Heterologous prime-boost Zika virus vaccination induces comprehensive humoral and cellular immunity in mouse models., PMID:40352923
Design, synthesis and biological evaluation of dapsone derivatives with broad-spectrum antiviral activity., PMID:40344737
Structural and functional characterization of the SLA' structure at the 3' terminus of the Zika virus negative-strand intermediate., PMID:40341208
A novel immunogen comprising a bc loop and mutant fusion loop epitopes generates potent neutralization and protective abilities against flaviviruses without risk of disease enhancement., PMID:40339178
Engineered antibody-mediated broad-spectrum suppression of human arboviruses in the Aedes aegypti vector., PMID:40335671
Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue disease., PMID:40333188
IFITMs exhibit antiviral activity against Chikungunya and Zika virus infection via the alteration of TLRs and RLRs signaling pathways., PMID:40328864
Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progress., PMID:40321006
mTOR Signalling in Arbovirus Infections: Molecular Mechanisms and Therapeutic Opportunities., PMID:40317563
Circadian misalignment potentiates blood-brain barrier disruption and mitochondria dysregulation in Zika virus infection., PMID:40313764
DENV2 and ZIKV modulate the feeding behavior of Aedes aegypti by altering the tyrosine-dopamine pathway., PMID:40298398
Structural basis of Zika virus NS1 multimerization and human antibody recognition., PMID:40295651
Targeting immunogenic proteins of Zika virus for the prediction of immunoinformatics-driven circular mRNA vaccine model., PMID:40291442
Evolution of Zika virus in Rag1-deficient mice selects for unique envelope glycosylation motif mutants that show enhanced replication fitness., PMID:40291117
Bothropstoxins I and II as potent phospholipase A2 molecules from Bothrops jararacussu to impair hepatitis C virus infection., PMID:40288437
Structural and functional significance of Aedes aegypti AgBR1 flavivirus immunomodulator., PMID:40272158
Orthoflavivirus infection and the mTOR signaling pathway., PMID:40270809
Prolonged Zika Virus NS1 Protein Circulation in Patient Sera Impacts Clinical Outcome Before the Rise of a Specific IgM Response., PMID:40263920
Neurological Manifestations of Zika Virus Infection: An Updated Review of the Existing Literature., PMID:40260336
The first trimester human placenta responds to Zika virus infection inducing an interferon (IFN) and antiviral interferon stimulated gene (ISG) response., PMID:40253335
Kyasanur Forest disease virus non-structural protein NS1 forms multimers in solution, with a distinctly identifiable tetrameric state., PMID:40252820
Modeling potential drugs for Zika virus in animal and in vitro platforms: what is the current state of the art?, PMID:40251755
Decoding potential host protein targets against Flaviviridae using protein-protein interaction network., PMID:40250655
An Updated Review of Potential Drug Targets for Japanese Encephalitis., PMID:40247803
Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines., PMID:40240603
Multi-omics analysis reveals key immunogenic signatures induced by oncolytic Zika virus infection of paediatric brain tumour cells., PMID:40240536
Developing Zika virus-transduced hACE2 expression models for severe acute respiratory syndrome coronavirus 2 infection in vitro and in vivo., PMID:40239870
Hedgehog pathway inhibitor HhAntag suppresses virus infection via the GLI-S1PR axis., PMID:40239727
Defining neuronal responses to the neurotropic parasite Toxoplasma gondii., PMID:40236177
mRNA-based vaccines and therapies - a revolutionary approach for conquering fast-spreading infections and other clinical applications: a review., PMID:40233916
For research use only. Not for human or drug use.
